GS
ZYNE

GTS Securities’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

GTS Securities’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-120,121
Closed -$153K – 2194
2023
Q3 		$153K Buy
+120,121
New +$153K ﹤0.01% 1202